View all cases
- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Claimants
- Meril Italy srlOperating co.
Representatives- Emmanuel Larere-Cabinet Gide Loyrette Nouel AARPI
- Raphaëlle Dequiré-Portiersupporting-Cabinet Gide Loyrette Nouel AARPI
Respondents- Edwards Lifesciences CorporationOperating co.
Representatives- Boris Kreye-Bird & Bird LLP
- Siddharth Kusumakar-Powell Gilbert (Europe) LLP
- Tessa Waldron-Powell Gilbert (Europe) LLP
- Division
- Paris CD
- Judges
- Technology
- InstrumentsMedical technology
- Language
- —
- First decided
- Feb 27, 2024
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Paris CD | Locked |
| Judge Paolo Catallozzi | Locked |
At the UPC: Meril Group (60 cases)·Edwards Lifesciences Group (57 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 6 other proceedings
UPC CoA 530/2024·UPC CoA 464/2024·UPC CFI 255/2023·CC 585030/2023·UPC APP 19959/2024 and 1 more
12 other defendants litigating the same or a related patent
UPC CFI 202/2025·UPC CoA 166/2025·UPC CoA 21/2025·UPC CoA 27/2025·UPC CFI 815/2024 and 7 more
Decisions
- 2024-02-27
Summary: Order by Central Division Paris (27 February 2024) on Meril Italy's application for a further round of written pleadings in the revocation action UPC_CFI_255/2023 concerning EP 3 646 825 (transcatheter heart valve). The court considered whether to exercise its discretion under R. 36 RoP to allow additional pleadings in response to new priority-related defence arguments raised in the defendant's rejoinder.
Show the legal issues (3)
- Further written pleadings (R. 36 RoP)
- Discretion to allow additional submissions
- Revocation action procedural management
Documents
- 90DB963FCEF5D99BAFDCA8EEEF9A8570_en.pdf2024-02-27EN